Zhengye Biotechnology Holding earnings were $4.4M for the trailing 12 months ending Dec 31, 2023, with -33.6% growth year over year. The latest ZYBT earnings report on Dec 31, 2023 announced Q4 2023 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ZYBT reported annual earnings of $4.4M, with -33.8% growth.
ZYBT past earnings growth
How has ZYBT's earnings growth performed historically?
Zhengye Biotechnology Holding Earnings Reports & History FAQ
What were Zhengye Biotechnology Holding's earnings last quarter?
Zhengye Biotechnology Holding (NASDAQ: ZYBT) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total ZYBT earnings for the quarter were N/A. In the same quarter last year, Zhengye Biotechnology Holding's earnings per share (EPS) was N/A.
Is Zhengye Biotechnology Holding profitable or losing money?
As of the last Zhengye Biotechnology Holding earnings report, Zhengye Biotechnology Holding is currently profitable. Zhengye Biotechnology Holding's net profit (also called net income) for the twelve months ending Dec 31, 2023 was $5.29 million, a 33.85% decrease year over year.
What was ZYBT's earnings growth in the past year?
As of Zhengye Biotechnology Holding's earnings date in Q2 2025, Zhengye Biotechnology Holding's earnings has grown -33.56% year over year. This is 45.3 percentage points lower than the US Biotechnology industry earnings growth rate of 11.74%. ZYBT earnings in the past year totalled $4.42 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.